Division of Cardiology

Medicine & Life Sciences

1. Heart Failure 100%
2. Myocardial Infarction 59%
3. Heart 49%
4. Mortality 34%
5. Percutaneous Coronary Intervention 32%
6. Registries 27%
7. Cardiovascular Diseases 25%
8. Coronary Artery Disease 25%
9. Heart-Assist Devices 23%
10. Therapeutics 23%
11. Cardiac Myocytes 23%
12. Heart Rate 21%
13. Cardiology 20%
14. Myocardium 19%
15. Atrial Fibrillation 19%
16. Cardiomyopathies 18%
17. Blood Pressure 18%
18. Echocardiography 18%
19. Nanoparticles 18%
20. Medicare 18%
21. Left Ventricular Function 17%
22. Stroke Volume 17%
23. Confidence Intervals 16%
24. Left Ventricular Dysfunction 16%
25. Cardiac Arrhythmias 16%
26. Stroke 15%
27. Coronary Vessels 15%
28. Infarction 15%
29. Pressure 15%
30. Molecular Imaging 14%
31. Angioplasty 14%
32. Heart Diseases 14%
33. Exercise 13%
34. Coronary Disease 13%
35. Genes 13%
36. Stents 13%
37. Hospitalization 13%
38. Myocardial Ischemia 13%
39. Muscle Cells 12%
40. Acute Coronary Syndrome 12%
41. Hemodynamics 12%
42. Equipment and Supplies 12%
43. Fatty Acids 12%
44. Population 12%
45. Ventricular Pressure 11%
46. Odds Ratio 11%
47. Elderly 11%
48. Macrophages 11%
49. Transcatheter Aortic Valve Replacement 11%
50. Lipids 11%
51. Hypertension 11%
52. Cardiac Resynchronization Therapy 11%
53. Atherosclerosis 10%
54. Fluorocarbons 10%
55. Transplants 10%
56. Survival 10%
57. Electrocardiography 10%
58. American Heart Association 10%
59. Ventricular Remodeling 10%
60. Tumor Necrosis Factor-alpha 9%
61. Thrombosis 9%
62. Heart Ventricles 9%
63. Blood Vessels 9%
64. Health 9%
65. Guidelines 9%
66. Diastole 9%
67. Proteins 9%
68. Hemorrhage 9%
69. Randomized Controlled Trials 9%
70. Dogs 9%
71. Contrast Media 9%
72. Aortic Valve 9%
73. Ultrasonics 9%
74. Cardiac Catheterization 9%
75. Safety 9%
76. Action Potentials 8%
77. Veterans 8%
78. Coronary Artery Bypass 8%
79. Biomarkers 8%
80. Inflammation 8%
81. Ischemia 8%
82. Dilated Cardiomyopathy 8%
83. Costs and Cost Analysis 8%
84. Heart Transplantation 8%
85. Cholesterol 8%
86. Cardiotoxicity 8%
87. Neoplasms 8%
88. Wounds and Injuries 8%
89. Phenotype 8%
90. Meta-Analysis 8%
91. Patient Readmission 8%
92. Dissecting Aneurysm 7%
93. Calcium 7%
94. Hypertrophy 7%
95. Mitral Valve 7%
96. Systolic Heart Failure 7%
97. Magnetic Resonance Imaging 7%
98. Mutation 7%
99. Quality of Life 7%
100. Pharmaceutical Preparations 7%